speb/financial-data huggingface dataset:
Financial ratios for ALNY — annual report dated 2025-12-31
Total revenue: 3713937000
Gross profit: 3032066000
Operating income: 501578000
Net income: 313747000
Capital expenditures: 58697000
Operating cash flow: 524080000
Depreciation & amortization: 55658000
Net tangible assets: 789176000
Owner earnings: 310708000
Return on net tangible assets (%): 39.371192230883864
Capex to operating income (%): 11.702467014103489
Buffett classification: The Great
Stock price: 397.65
P/E ratio: 169.21683602855165
Shares outstanding: 133512573
Book value: 789176000
P/B ratio: 67.27431479600241
Market cap (USD): 53091274653.45
Debt to equity: 1.619903544963354
Current ratio: 2.76241331361088
Quick ratio: 2.7060017772031077
Effective tax rate (%): 2.9103951081843835
Interest coverage ratio: 1.9854489029280322
COGS to revenue (%): 18.3597890863523
R&D to revenue (%): 35.53574010544605
SG&A to revenue (%): 32.59917979222588
Free cash flow (dilution-adjusted): 117148000
Buyback yield (%): 0
Retained earnings: -6702524000
Inventory turnover: 8.243221025399244
Receivables turnover: 4.776356249686522
Capitalized R&D asset: 2405807390
ROCI (R&D-adjusted, %): 11.365327969024193
Rosenberg metric: 0.9830949573444903
FCF margin (%): 3.1542807538200024
Revenue growth (%): 65.19286393864009
Rule of 40 score: 68.34714469246009
Financial ratios for AMST — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 33
Shares outstanding: 5852985
Market cap (USD): 193148505
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMST — annual report dated 2022-06-30
Total revenue: 697001
Operating income: -9056518
Net income: -9059923
Capital expenditures: 16575
Operating cash flow: -6715652
Depreciation & amortization: 875604
Net tangible assets: 7069078
Owner earnings: -8200894
Return on net tangible assets (%): -116.01080084276903
Buffett classification: The Gruesome
Stock price: 5.52
Shares outstanding: 5852985
Book value: 8135752
P/B ratio: 3.971172818443826
Market cap (USD): 32308477.2
Debt to equity: 0
Current ratio: 10.332727360220717
Quick ratio: 10.332727360220717
Interest coverage ratio: -716.780213692125
COGS to revenue (%): 0
R&D to revenue (%): 439.01830843858187
SG&A to revenue (%): 960.3367857434926
Free cash flow (dilution-adjusted): -8869361
Buyback yield (%): 0
Retained earnings: -29277016
Receivables turnover: 47.92031625988312
Capitalized R&D asset: 3059962
ROCI (R&D-adjusted, %): -62.67169144668516
FCF margin (%): -1272.5033393065432
Rule of 40 score: -1272.5033393065432
Financial ratios for AMST — annual report dated 2023-06-30
Total revenue: 845009
Operating income: -4224508
Net income: -4153303
Capital expenditures: 27124
Operating cash flow: -3249176
Depreciation & amortization: 682483
Net tangible assets: 5305979
Owner earnings: -3497944
Return on net tangible assets (%): -65.92457301470662
Buffett classification: The Gruesome
Stock price: 3.61
Shares outstanding: 5852985
Book value: 6084425
P/B ratio: 3.472682439178722
Market cap (USD): 21129275.849999998
Debt to equity: 0
Current ratio: 20.662578629389394
Quick ratio: 20.662578629389394
Interest coverage ratio: -2609.3316862260654
COGS to revenue (%): 0
R&D to revenue (%): 180.2994997686415
SG&A to revenue (%): 419.63695061236035
Free cash flow (dilution-adjusted): -3824743
Buyback yield (%): 0
Retained earnings: -33430319
Receivables turnover: 56.333933333333334
Capitalized R&D asset: 3573721.54
ROCI (R&D-adjusted, %): -43.78477087523393
FCF margin (%): -452.62748680783284
Revenue growth (%): 21.23497670735049
Rule of 40 score: -431.39251010048235
Financial ratios for AMST — annual report dated 2024-06-30
Total revenue: 166881
Operating income: -4579651
Net income: -4403182
Capital expenditures: 1166
Operating cash flow: -2813779
Depreciation & amortization: 533667
Net tangible assets: 1870884
Owner earnings: -3870681
Return on net tangible assets (%): -206.89048599485588
Buffett classification: The Gruesome
Stock price: 3
Shares outstanding: 5852985
Book value: 2515712
P/B ratio: 6.97971588162715
Market cap (USD): 17558955
Debt to equity: 0
Current ratio: 3.1367248407882626
Quick ratio: 3.1367248407882626
COGS to revenue (%): 0
R&D to revenue (%): 643.7689131776535
SG&A to revenue (%): 2200.4925665594046
Free cash flow (dilution-adjusted): -4024114
Buyback yield (%): 0
Retained earnings: -37833501
Receivables turnover: 5.551596806387225
Capitalized R&D asset: 3104891.95
ROCI (R&D-adjusted, %): -95.91973949110339
FCF margin (%): -2411.3673815473303
Revenue growth (%): -80.25097957536546
Rule of 40 score: -2491.6183611226957
Financial ratios for AMST — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.45
Shares outstanding: 5852985
Market cap (USD): 14339813.250000002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMST — quarterly report dated 2024-12-31
Operating income: -1130869
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.75
Shares outstanding: 5852985
Market cap (USD): 27801678.75
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMST — quarterly report dated 2025-03-31
Total revenue: 30690
Operating income: -687722
Net income: -663418
Capital expenditures: 0
Operating cash flow: -677093
Depreciation & amortization: 100509
Net tangible assets: 2973943
Owner earnings: -562909
Return on net tangible assets (%): -18.928035944199333
Buffett classification: The Gruesome
Stock price: 2.42
Shares outstanding: 5852985
Book value: 3598262
P/B ratio: 3.9364069931539167
Market cap (USD): 14164223.7
Debt to equity: 0
Current ratio: 14.880609042729695
Quick ratio: 14.880609042729695
COGS to revenue (%): 0
R&D to revenue (%): 560.7624633431085
SG&A to revenue (%): 1780.1042684913655
Free cash flow (dilution-adjusted): -612084
Buyback yield (%): 0
Retained earnings: -40526601
Receivables turnover: 6.912162162162162
Capitalized R&D asset: 172098
ROCI (R&D-adjusted, %): -15.197222546388142
FCF margin (%): -1994.4086021505377
Rule of 40 score: -1994.4086021505377
Financial ratios for AMST — quarterly report dated 2025-06-30
Total revenue: 55759
Operating income: -857678
Net income: -923986
Capital expenditures: 0
Operating cash flow: -439444
Depreciation & amortization: 102084
Net tangible assets: 2214699
Owner earnings: -821902
Return on net tangible assets (%): -37.1112282075352
Buffett classification: The Gruesome
Stock price: 2.69
Shares outstanding: 5852985
Book value: 2738503
P/B ratio: 5.749319847376468
Market cap (USD): 15744529.65
Debt to equity: 0
Current ratio: 6.78718948342982
Quick ratio: 6.78718948342982
COGS to revenue (%): 0
R&D to revenue (%): 300.45553184239316
SG&A to revenue (%): 1337.7320253232663
Free cash flow (dilution-adjusted): -789772
Buyback yield (%): 0
Retained earnings: -41450587
Receivables turnover: 8.79340797981391
Capitalized R&D asset: 282836.66000000003
ROCI (R&D-adjusted, %): -26.58941916734601
FCF margin (%): -1416.4027331910545
Revenue growth (%): 81.68458781362007
Rule of 40 score: -1334.7181453774344
Financial ratios for AMST — annual report dated 2025-06-30
Total revenue: 110459
Operating income: -3603613
Net income: -3617086
Capital expenditures: 0
Operating cash flow: -2455248
Depreciation & amortization: 433803
Net tangible assets: 2214699
Owner earnings: -3183283
Return on net tangible assets (%): -143.73434042278433
Buffett classification: The Gruesome
Stock price: 2.69
Shares outstanding: 5852985
Book value: 2738503
P/B ratio: 5.749319847376468
Market cap (USD): 15744529.65
Debt to equity: 0
Current ratio: 6.78718948342982
Quick ratio: 6.78718948342982
COGS to revenue (%): 0
R&D to revenue (%): 625.7108972559954
SG&A to revenue (%): 2736.687820820395
Free cash flow (dilution-adjusted): -3059601
Buyback yield (%): 0
Retained earnings: -41450587
Receivables turnover: 17.419807601324713
Capitalized R&D asset: 1913724.27
ROCI (R&D-adjusted, %): -86.16952198038254
FCF margin (%): -2769.897428004961
Revenue growth (%): -33.80972069918085
Rule of 40 score: -2803.707148704142
Financial ratios for AMST — quarterly report dated 2025-09-30
Total revenue: 94296
Operating income: -662124
Net income: -642266
Capital expenditures: 87600
Operating cash flow: -415765
Depreciation & amortization: 60440
Net tangible assets: 1611188
Owner earnings: -669426
Return on net tangible assets (%): -41.548596439397514
Buffett classification: The Gruesome
Stock price: 3.05
Shares outstanding: 5852985
Book value: 2168489
P/B ratio: 8.232277982503023
Market cap (USD): 17851604.25
Debt to equity: 0
Current ratio: 4.45641046027355
Quick ratio: 4.45641046027355
COGS to revenue (%): 0
R&D to revenue (%): 109.11173326546195
SG&A to revenue (%): 693.0643929753118
Free cash flow (dilution-adjusted): -575617
Buyback yield (%): 0
Retained earnings: -42092853
Receivables turnover: 9.116009280742459
Capitalized R&D asset: 271926.11000000004
ROCI (R&D-adjusted, %): -28.95989554279832
FCF margin (%): -610.4362857385255
Revenue growth (%): 69.11350633978371
Rule of 40 score: -541.3227793987418
Financial ratios for AMST — quarterly report dated 2025-12-31
Total revenue: 108050
Operating income: -745253
Net income: -732548
Capital expenditures: 43600
Operating cash flow: -621084
Depreciation & amortization: 67740
Net tangible assets: 968695
Owner earnings: -708408
Return on net tangible assets (%): -73.13013900144009
Buffett classification: The Gruesome
Stock price: 1.89
Shares outstanding: 5852985
Book value: 1508193
P/B ratio: 7.334698974202904
Market cap (USD): 11062141.649999999
Debt to equity: 0
Current ratio: 2.718967312521693
Quick ratio: 2.718967312521693
COGS to revenue (%): 0
R&D to revenue (%): 152.57103192966218
SG&A to revenue (%): 637.1587228135122
Free cash flow (dilution-adjusted): -736936
Buyback yield (%): 0
Retained earnings: -42825401
Receivables turnover: 15.013199944421286
Capitalized R&D asset: 289073.19
ROCI (R&D-adjusted, %): -40.36634476869933
FCF margin (%): -682.0323924109209
Revenue growth (%): 14.5859845592602
Rule of 40 score: -667.4464078516608
Financial ratios for AMT — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 252.6
Shares outstanding: 465893069
Market cap (USD): 117684589229.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMT — annual report dated 2022-12-31
Total revenue: 9645400000
Gross profit: 7076200000
Operating income: 2922700000
Net income: 1765800000
Capital expenditures: 1873600000
Operating cash flow: 3696200000
Depreciation & amortization: 3355100000
Net tangible assets: -25367600000
Owner earnings: 3247300000
Return on net tangible assets (%): -12.800974471372934
Capex to operating income (%): 64.10510829027953
Buffett classification: The Good
Stock price: 187.76
P/E ratio: 49.53906593920036
Shares outstanding: 465893069
Book value: 12408500000
P/B ratio: 7.04969034415441
Market cap (USD): 87476082635.44
Debt to equity: 3.791836241286215
Current ratio: 0.4357968695484787
Quick ratio: 0.4357968695484787
Effective tax rate (%): 5.407478427612656
Interest coverage ratio: 2.5727992957746477
COGS to revenue (%): 26.63653140357061
SG&A to revenue (%): 9.352644784042134
Free cash flow (dilution-adjusted): 1653300000
Buyback yield (%): 0.021491588824741656
Retained earnings: -2101900000
Receivables turnover: 8.56835746646531
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.963605547309392
FCF margin (%): 17.140813237398138
Rule of 40 score: 17.140813237398138
Financial ratios for AMT — annual report dated 2023-12-31
Total revenue: 10012200000
Gross profit: 7450700000
Operating income: 3536800000
Net income: 1483300000
Capital expenditures: 1798100000
Operating cash flow: 4722400000
Depreciation & amortization: 3086500000
Net tangible assets: -23817600000
Owner earnings: 2771700000
Return on net tangible assets (%): -11.637192664248287
Capex to operating income (%): 50.83974213978738
Buffett classification: The Good
Stock price: 197.84
P/E ratio: 62.14001535155397
Shares outstanding: 465893069
Book value: 10865400000
P/B ratio: 8.483100923202091
Market cap (USD): 92172284770.96
Debt to equity: 4.261877151324388
Current ratio: 0.5117735505497083
Quick ratio: 0.5117735505497083
Effective tax rate (%): 5.937356960700974
Interest coverage ratio: 2.5477596888056477
COGS to revenue (%): 25.583787778909727
SG&A to revenue (%): 9.448472863107009
Free cash flow (dilution-adjusted): 2728600000
Buyback yield (%): 0
Retained earnings: -3638800000
Receivables turnover: 12.312100344318742
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.017186614788111
FCF margin (%): 27.25275164299554
Revenue growth (%): 3.802849026478943
Rule of 40 score: 31.055600669474483
Financial ratios for AMT — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 216.83
Shares outstanding: 465893069
Market cap (USD): 101019594151.27
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMT — annual report dated 2024-12-31
Total revenue: 10127200000
Gross profit: 7552800000
Operating income: 4603000000
Net income: 2280200000
Capital expenditures: 1590000000
Operating cash flow: 5290500000
Depreciation & amortization: 2124800000
Net tangible assets: -22860200000
Owner earnings: 2815000000
Return on net tangible assets (%): -12.313978005441772
Capex to operating income (%): 34.54268955029329
Buffett classification: The Good
Stock price: 173.78
P/E ratio: 35.506928133856675
Shares outstanding: 465893069
Book value: 9648700000
P/B ratio: 8.391067970899707
Market cap (USD): 80962897530.82
Debt to equity: 4.555442702125675
Current ratio: 0.4492622533778054
Quick ratio: 0.4492622533778054
Effective tax rate (%): 10.105385124696536
Interest coverage ratio: 3.277322890708437
COGS to revenue (%): 25.420649340390238
SG&A to revenue (%): 9.216762777470574
Free cash flow (dilution-adjusted): 3496900000
Buyback yield (%): 0
Retained earnings: -4424100000
Receivables turnover: 12.904179408766565
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.523789947742483
FCF margin (%): 34.52978118334782
Revenue growth (%): 1.1485987095743193
Rule of 40 score: 35.678379892922145
Financial ratios for AMT — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 173.78
Shares outstanding: 465893069
Market cap (USD): 80962897530.82
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMT — quarterly report dated 2025-03-31
Total revenue: 2562800000
Gross profit: 1928300000
Operating income: 1254100000
Net income: 498600000
Capital expenditures: 331100000
Operating cash flow: 1295000000
Depreciation & amortization: 492500000
Net tangible assets: -23029200000
Owner earnings: 660000000
Return on net tangible assets (%): -2.8659267364910637
Capex to operating income (%): 26.401403396858303
Buffett classification: The Good
Stock price: 206.17
P/E ratio: 48.16143904719714
Shares outstanding: 465893069
Book value: 9936300000
P/B ratio: 9.666895528086913
Market cap (USD): 96053174035.73
Debt to equity: 4.466813602648873
Current ratio: 0.5545871559633028
Quick ratio: 0.5545871559633028
Effective tax rate (%): 19.255060728744937
Interest coverage ratio: 3.855210574853981
COGS to revenue (%): 24.75807710316841
SG&A to revenue (%): 9.2672077415327
Free cash flow (dilution-adjusted): 910500000
Buyback yield (%): 0
Retained earnings: -4732500000
Receivables turnover: 2.6467004027677374
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.2501686594800985
FCF margin (%): 35.527547994381145
Rule of 40 score: 35.527547994381145
Financial ratios for AMT — quarterly report dated 2025-06-30
Total revenue: 2626900000
Gross profit: 1938200000
Operating income: 1197700000
Net income: 380500000
Capital expenditures: 304600000
Operating cash flow: 1281500000
Depreciation & amortization: 510300000
Net tangible assets: -23495800000
Owner earnings: 586200000
Return on net tangible assets (%): -2.49491398462704
Capex to operating income (%): 25.432078149787092
Buffett classification: The Good
Stock price: 212.8
P/E ratio: 112.77675473006485
Shares outstanding: 465893069
Book value: 10478900000
P/B ratio: 9.46111186128315
Market cap (USD): 99142045083.20001
Debt to equity: 4.3146895189380565
Current ratio: 0.6141960570298111
Quick ratio: 0.6141960570298111
Effective tax rate (%): 25.65455255959359
Interest coverage ratio: 3.4959136018680677
COGS to revenue (%): 26.217214206859797
SG&A to revenue (%): 8.896417830903346
Free cash flow (dilution-adjusted): 929600000
Buyback yield (%): 0
Retained earnings: -5164400000
Receivables turnover: 2.48430111594477
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.068891656547057
FCF margin (%): 35.387719365031025
Revenue growth (%): 2.5011705946620886
Rule of 40 score: 37.88888995969312
Financial ratios for AMT — quarterly report dated 2025-09-30
Total revenue: 2717400000
Gross profit: 2006600000
Operating income: 1233300000
Net income: 912600000
Capital expenditures: 465500000
Operating cash flow: 1460000000
Depreciation & amortization: 522900000
Net tangible assets: -23045200000
Owner earnings: 970000000
Return on net tangible assets (%): -4.20911946956416
Capex to operating income (%): 37.74426335846915
Buffett classification: The Good
Stock price: 186.8
P/E ratio: 48.573324378634815
Shares outstanding: 465893069
Book value: 10765900000
P/B ratio: 8.08374825042031
Market cap (USD): 87028825289.20001
Debt to equity: 4.180904522613066
Current ratio: 0.5898723617252023
Quick ratio: 0.5898723617252023
Effective tax rate (%): 3.936842105263158
Interest coverage ratio: 3.5531547104580814
COGS to revenue (%): 26.15735629645985
SG&A to revenue (%): 8.5743725620078
Free cash flow (dilution-adjusted): 952600000
Buyback yield (%): 0
Retained earnings: -5111300000
Receivables turnover: 2.7174
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.1302284127181528
FCF margin (%): 35.05556782218297
Revenue growth (%): 3.4451254330199093
Rule of 40 score: 38.50069325520288
Financial ratios for AMT — annual report dated 2025-12-31
Total revenue: 10644600000
Gross profit: 7896500000
Operating income: 4929200000
Net income: 2628500000
Capital expenditures: 1680400000
Operating cash flow: 5464000000
Depreciation & amortization: 2041600000
Net tangible assets: -23133700000
Owner earnings: 2989700000
Return on net tangible assets (%): -12.923570375685689
Capex to operating income (%): 34.09072466120263
Buffett classification: The Good
Stock price: 172.19
P/E ratio: 30.520117006319193
Shares outstanding: 465893069
Book value: 10355300000
P/B ratio: 7.746963154240823
Market cap (USD): 80222127551.11
Debt to equity: 4.342114665919867
Current ratio: 0.3965691804796205
Quick ratio: 0.3965691804796205
Effective tax rate (%): 13.655475987123053
Interest coverage ratio: 3.6260114756510227
COGS to revenue (%): 25.81684610037014
SG&A to revenue (%): 8.837344756965972
Free cash flow (dilution-adjusted): 3609400000
Buyback yield (%): 0.45448807097232763
Retained earnings: -5086000000
Receivables turnover: 11.965602517985612
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.758880245075218
FCF margin (%): 33.908272739229275
Revenue growth (%): 5.109013350185639
Rule of 40 score: 39.01728608941492
Financial ratios for AMT — quarterly report dated 2025-12-31
Total revenue: 2737500000
Gross profit: 2023400000
Operating income: 1244100000
Net income: 836800000
Capital expenditures: 579200000
Operating cash flow: 1427500000
Depreciation & amortization: 515900000
Net tangible assets: -23133700000
Owner earnings: 773500000
Return on net tangible assets (%): -3.3436069457112354
Capex to operating income (%): 46.555743107467244
Buffett classification: The Good
Stock price: 172.19
P/E ratio: 30.520117006319193
Shares outstanding: 465893069
Book value: 10355300000
P/B ratio: 7.746963154240823
Market cap (USD): 80222127551.11
Debt to equity: 4.342114665919867
Current ratio: 0.3965691804796205
Quick ratio: 0.3965691804796205
Effective tax rate (%): 13.275987148927351
Interest coverage ratio: 3.612369337979094
COGS to revenue (%): 26.08584474885845
SG&A to revenue (%): 8.639269406392694
Free cash flow (dilution-adjusted): 816700000
Buyback yield (%): 0
Retained earnings: -5086000000
Receivables turnover: 3.0772257194244603
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.2106879235774723
FCF margin (%): 29.833789954337895
Revenue growth (%): 0.7396776330315743
Rule of 40 score: 30.57346758736947
Financial ratios for ARK.L — annual report dated 2021-12-31
Total revenue: 0
Operating income: -392946.5909090909
Net income: 484386.36363636365
Capital expenditures: 519990.9090909091
Operating cash flow: -306820.45454545453
Net tangible assets: 4033919.3181818184
Owner earnings: -35604.54545454547
Return on net tangible assets (%): -0.8826290921106789
Buffett classification: The Gruesome
Stock price: 0.00013513513513513514
P/E ratio: 0.4450632456779963
Shares outstanding: 1595310997
Book value: 4033919.3181818184
P/B ratio: 0.05344245884901096
Market cap (USD): 215582.56716216216
Debt to equity: 0
Current ratio: 0.2853886731852093
Quick ratio: 0.2853886731852093
Effective tax rate (%): 0
Free cash flow (dilution-adjusted): -860101.1363636364
Buyback yield (%): 0
Retained earnings: -5732026.136363637
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.741062225463674
Rule of 40 score: 0
Financial ratios for ARK.L — annual report dated 2022-12-31
Total revenue: 0
Operating income: -309515.9574468085
Net income: -318312.7659574468
Capital expenditures: 170152.12765957447
Operating cash flow: -184374.4680851064
Net tangible assets: 3953672.3404255323
Owner earnings: -488464.89361702127
Return on net tangible assets (%): -12.35471358166337
Buffett classification: The Gruesome
Stock price: 0.00012048192771084338
Shares outstanding: 1595310997
Book value: 3953672.340425532
P/B ratio: 0.04861458605246494
Market cap (USD): 192206.14421686748
Debt to equity: 0
Current ratio: 0.4297460585807775
Quick ratio: 0.4297460585807775
Free cash flow (dilution-adjusted): -354526.59574468085
Buyback yield (%): 0
Retained earnings: -5684464.893617022
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.828568753208706
Rule of 40 score: 0
Financial ratios for ARK.L — annual report dated 2023-12-31
Total revenue: 0
Operating income: -310568.8888888889
Net income: -330023.3333333333
Capital expenditures: 109604.44444444444
Operating cash flow: -287938.8888888889
Net tangible assets: 4072843.333333333
Owner earnings: -439627.77777777775
Return on net tangible assets (%): -10.794124443229531
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 1595310997
Book value: 4072843.333333333
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0
Current ratio: 0.17805022694766057
Quick ratio: 0.17805022694766057
Free cash flow (dilution-adjusted): -397543.3333333333
Retained earnings: -6267131.111111111
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.625358096814155
Rule of 40 score: 0
Financial ratios for ARK.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 2065363.5416666667
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 1595310997
Book value: 2065363.5416666665
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0
Current ratio: 0.044975902282291265
Quick ratio: 0.044975902282291265
Retained earnings: -7960591.666666667
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARK.L — annual report dated 2024-12-31
Total revenue: 0
Operating income: -283639.5833333334
Net income: -2085156.25
Capital expenditures: 260797.9166666667
Operating cash flow: -138983.33333333334
Net tangible assets: 2065363.5416666667
Owner earnings: -2345954.1666666665
Return on net tangible assets (%): -113.5855320063205
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 1595310997
Book value: 2065363.5416666665
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0
Current ratio: 0.044975902282291265
Quick ratio: 0.044975902282291265
Free cash flow (dilution-adjusted): -399781.25
Retained earnings: -7960591.666666667
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.733155331310218
Rule of 40 score: 0
Financial ratios for ATC.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.03007518796992481
Shares outstanding: 2669056318
Market cap (USD): 80272370.46616541
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ATC.AX — annual report dated 2022-06-30
Operating income: -4189724.827586207
Net income: -3951668.275862069
Capital expenditures: 1684977.9310344828
Depreciation & amortization: 226821.37931034484
Net tangible assets: 67317346.89655173
Owner earnings: -5409824.827586207
Return on net tangible assets (%): -8.036301305664379
Buffett classification: The Gruesome
Stock price: 0.034482758620689655
Shares outstanding: 2669056318
Book value: 67267340
P/B ratio: 1.3682185851056499
Market cap (USD): 92036424.7586207
Debt to equity: 0.0009219619957394296
Current ratio: 16.60655921330172
Quick ratio: 16.60655921330172
Interest coverage ratio: -1786.7944117647057
Free cash flow (dilution-adjusted): -5132941.379310345
Buyback yield (%): 0.3157100861144137
Retained earnings: -21106547.586206898
Capitalized R&D asset: 376732.4137931035
ROCI (R&D-adjusted, %): -5.812824803366866
Rule of 40 score: 0
Financial ratios for ATC.AX — annual report dated 2023-06-30
Operating income: -8975254.304635761
Net income: -39547990.06622516
Capital expenditures: 2160279.4701986755
Depreciation & amortization: 230311.9205298013
Net tangible assets: 23833364.238410596
Owner earnings: -41477957.61589404
Return on net tangible assets (%): -174.03316292647796
Buffett classification: The Gruesome
Stock price: 0.059602649006622516
Shares outstanding: 2669056318
Book value: 22433813.90728477
P/B ratio: 7.091207387122188
Market cap (USD): 159082826.90066224
Debt to equity: 0.12630079847241002
Current ratio: 0.98031715825812
Quick ratio: 0.98031715825812
Interest coverage ratio: -237.81140220042462
Free cash flow (dilution-adjusted): -10286323.841059603
Buyback yield (%): 0
Retained earnings: -59815866.88741722
Capitalized R&D asset: 2735000.783466545
ROCI (R&D-adjusted, %): -26.502583029949083
Rule of 40 score: 0
Financial ratios for ATC.AX — annual report dated 2024-06-30
Operating income: -13686455.333333334
Net income: -18707952.666666668
Capital expenditures: 6244788
Depreciation & amortization: 266469.3333333333
Net tangible assets: 19321252
Owner earnings: -24686271.333333336
Return on net tangible assets (%): -127.76745178487054
Buffett classification: The Gruesome
Stock price: 0.03333333333333333
Shares outstanding: 2669056318
Book value: 15091206.666666666
P/B ratio: 5.895389672838179
Market cap (USD): 88968543.93333334
Debt to equity: 0.417365874431954
Current ratio: 1.051307602043402
Quick ratio: 1.051307602043402
Free cash flow (dilution-adjusted): -18444015.333333332
Buyback yield (%): 0.7123948592530224
Retained earnings: -78916770
Capitalized R&D asset: 5788617.707589252
ROCI (R&D-adjusted, %): -43.92310437992455
Rule of 40 score: 0
Financial ratios for BBIO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.68
Shares outstanding: 195861242
Market cap (USD): 3266965516.56
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BBIO — annual report dated 2022-12-31
Total revenue: 77648000
Gross profit: 74214000
Operating income: -468437000
Net income: -481183000
Capital expenditures: 4821000
Operating cash flow: -419494000
Depreciation & amortization: 6771000
Net tangible assets: -1283329000
Owner earnings: -479233000
Buffett classification: The Gruesome
Stock price: 7.62
Shares outstanding: 195861242
Book value: -1244924000
Market cap (USD): 1492462664.04
Debt to equity: -1.3844732690509622
Current ratio: 4.519987152880719
Quick ratio: 4.519987152880719
Interest coverage ratio: -5.823578408215023
COGS to revenue (%): 4.4225221512466515
R&D to revenue (%): 514.4524005769628
SG&A to revenue (%): 184.4078405110241
Free cash flow (dilution-adjusted): -517374000
Buyback yield (%): 0.10459223119019098
Retained earnings: -1918149000
Receivables turnover: 4.5464020141694474
Capitalized R&D asset: 399462000
ROCI (R&D-adjusted, %): -22.43210849323582
FCF margin (%): -666.3069235524417
Rule of 40 score: -666.3069235524417
Financial ratios for BBIO — annual report dated 2023-12-31
Total revenue: 9303000
Gross profit: 6857000
Operating income: -599444000
Net income: -643202000
Capital expenditures: 1306000
Operating cash flow: -527720000
Depreciation & amortization: 6494000
Net tangible assets: -1380576000
Owner earnings: -638014000
Buffett classification: The Gruesome
Stock price: 40.37
Shares outstanding: 195861242
Book value: -1342535000
Market cap (USD): 7906918339.54
Debt to equity: -1.2959349290707505
Current ratio: 3.3202149550902367
Quick ratio: 3.3202149550902367
Interest coverage ratio: -7.374232676007824
COGS to revenue (%): 26.292593786950448
R&D to revenue (%): 4898.538105987316
SG&A to revenue (%): 1618.725142427174
Free cash flow (dilution-adjusted): -637736000
Buyback yield (%): 0.08701240742041427
Retained earnings: -2560501000
Receivables turnover: 5.31296402055968
Capitalized R&D asset: 723350540
ROCI (R&D-adjusted, %): -38.08471381731472
Rosenberg metric: -0.16861929294901642
FCF margin (%): -6855.165000537461
Revenue growth (%): -88.01900886049866
Rule of 40 score: -6943.18400939796
Financial ratios for BBIO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 25.46
Shares outstanding: 195861242
Market cap (USD): 4986627221.32
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BBIO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 27.44
Shares outstanding: 195861242
Market cap (USD): 5374432480.4800005
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BBIO — annual report dated 2024-12-31
Total revenue: 221902000
Gross profit: 218024000
Operating income: -577368000
Net income: -535762000
Capital expenditures: 933000
Operating cash flow: -520726000
Depreciation & amortization: 6075000
Net tangible assets: -1491830000
Owner earnings: -530620000
Buffett classification: The Gruesome
Stock price: 27.44
Shares outstanding: 195861242
Book value: -1457612000
Market cap (USD): 5374432480.4800005
Debt to equity: -1.187273430789538
Current ratio: 4.667694300518135
Quick ratio: 4.667694300518135
Interest coverage ratio: -5.814966260449189
COGS to revenue (%): 1.7476183179962326
R&D to revenue (%): 228.23633856387056
SG&A to revenue (%): 130.20657767843463
Free cash flow (dilution-adjusted): -625434000
Buyback yield (%): 0.14003339008043206
Retained earnings: -3096263000
Receivables turnover: 46.99322321050403
Capitalized R&D asset: 943609830
ROCI (R&D-adjusted, %): -30.715265372465456
Rosenberg metric: 0.4633792030475455
FCF margin (%): -281.85144793647646
Revenue growth (%): 2285.273567666344
Rule of 40 score: 2003.4221197298677
Financial ratios for BBIO — quarterly report dated 2025-03-31
Total revenue: 116633000
Gross profit: 113994000
Operating income: -103802000
Net income: -167422000
Capital expenditures: 0
Operating cash flow: -199235000
Depreciation & amortization: 1284000
Net tangible assets: -1676197000
Owner earnings: -166138000
Buffett classification: The Gruesome
Stock price: 34.57
Shares outstanding: 195861242
Book value: -1638665000
Market cap (USD): 6770923135.94
Debt to equity: -1.1340011533779022
Current ratio: 4.570349429670293
Quick ratio: 4.544354228986555
Interest coverage ratio: -2.4632068531833604
COGS to revenue (%): 2.262652936990389
R&D to revenue (%): 95.53985578695567
SG&A to revenue (%): 91.19631665137653
Free cash flow (dilution-adjusted): -226712000
Buyback yield (%): 0.7392197340762064
Retained earnings: -3263685000
Inventory turnover: 0.667425392008093
Receivables turnover: 1.011868303474602
Capitalized R&D asset: 111431000
ROCI (R&D-adjusted, %): -3.509623083350377
FCF margin (%): -194.38066413450738
Rule of 40 score: -194.38066413450738
Financial ratios for BBIO — quarterly report dated 2025-06-30
Total revenue: 110565000
Gross profit: 106912000
Operating income: -133473000
Net income: -181903000
Capital expenditures: 594000
Operating cash flow: -80681000
Depreciation & amortization: 1317000
Net tangible assets: -1817373000
Owner earnings: -181180000
Buffett classification: The Gruesome
Stock price: 43.18
Shares outstanding: 195861242
Book value: -1778419000
Market cap (USD): 8457288429.56
Debt to equity: -1.0449539731638045
Current ratio: 5.187695474655111
Quick ratio: 5.083762666757651
Interest coverage ratio: -3.546324095969392
COGS to revenue (%): 3.3039388594944152
R&D to revenue (%): 100.6023606023606
SG&A to revenue (%): 116.81273459051238
Free cash flow (dilution-adjusted): -123016000
Buyback yield (%): 0.023589120988555336
Retained earnings: -3445588000
Inventory turnover: 0.19986868742134925
Receivables turnover: 1.4383748764115107
Capitalized R&D asset: 185889770
ROCI (R&D-adjusted, %): -8.847953269960467
Rosenberg metric: -0.06355502508278665
FCF margin (%): -111.26124903902681
Revenue growth (%): -5.202644191609579
Rule of 40 score: -116.46389323063639
Financial ratios for BBIO — quarterly report dated 2025-09-30
Total revenue: 120700000
Gross profit: 114137000
Operating income: -136358000
Net income: -182743000
Capital expenditures: 470000
Operating cash flow: -109574000
Depreciation & amortization: 1398000
Net tangible assets: -1961865000
Owner earnings: -181815000
Buffett classification: The Gruesome
Stock price: 51.94
Shares outstanding: 195861242
Book value: -1922729000
Market cap (USD): 10173032909.48
Debt to equity: -0.9672382327410675
Current ratio: 3.8752631578947367
Quick ratio: 3.7620267774699907
Interest coverage ratio: -2.832000664603626
COGS to revenue (%): 5.437448218724109
R&D to revenue (%): 93.51615575807787
SG&A to revenue (%): 114.01905550952776
Free cash flow (dilution-adjusted): -147706000
Buyback yield (%): 0.029735478366349103
Retained earnings: -3628331000
Inventory turnover: 0.26758266400293557
Receivables turnover: 1.0358914502480303
Capitalized R&D asset: 224171000
ROCI (R&D-adjusted, %): -13.454614025093264
Rosenberg metric: 0.06495491364817362
FCF margin (%): -122.3744821872411
Revenue growth (%): 9.166553610998056
Rule of 40 score: -113.20792857624305
Financial ratios for BBIO — quarterly report dated 2025-12-31
Total revenue: 154178000
Gross profit: 146071000
Operating income: -128431000
Net income: -192863000
Capital expenditures: 33000
Operating cash flow: -56420000
Depreciation & amortization: 1435000
Net tangible assets: -2114687000
Owner earnings: -191461000
Buffett classification: The Gruesome
Stock price: 76.49
Shares outstanding: 195861242
Book value: -2076581000
Market cap (USD): 14981426400.58
Debt to equity: -0.8968939810197628
Current ratio: 2.7702407534091975
Quick ratio: 2.6773390376114263
Interest coverage ratio: -2.552589736455062
COGS to revenue (%): 5.258208045246404
R&D to revenue (%): 75.50817885820285
SG&A to revenue (%): 102.53408398085331
Free cash flow (dilution-adjusted): -91092000
Buyback yield (%): 0.049594743526640096
Retained earnings: -3821194000
Inventory turnover: 0.3030314357268344
Receivables turnover: 1.105662488167293
Capitalized R&D asset: 228748810
ROCI (R&D-adjusted, %): -14.315799618996811
Rosenberg metric: 0.2829172351471552
FCF margin (%): -59.082359350880154
Revenue growth (%): 27.736536868268434
Rule of 40 score: -31.34582248261172
Financial ratios for BBIO — annual report dated 2025-12-31
Total revenue: 502076000
Gross profit: 481114000
Operating income: -502064000
Net income: -724931000
Capital expenditures: 1097000
Operating cash flow: -445910000
Depreciation & amortization: 5434000
Net tangible assets: -2114687000
Owner earnings: -720594000
Buffett classification: The Gruesome
Stock price: 76.49
Shares outstanding: 195861242
Book value: -2076581000
Market cap (USD): 14981426400.58
Debt to equity: -0.8968939810197628
Current ratio: 2.7702407534091975
Quick ratio: 2.6773390376114263
Interest coverage ratio: -2.8167705522298463
COGS to revenue (%): 4.175065129581975
R&D to revenue (%): 90.01685003863957
SG&A to revenue (%): 105.8056947553757
Free cash flow (dilution-adjusted): -588526000
Buyback yield (%): 0.41719658948883703
Retained earnings: -3821194000
Inventory turnover: 0.7835382947706799
Receivables turnover: 3.600556495797596
Capitalized R&D asset: 941666500
ROCI (R&D-adjusted, %): -32.80362805914624
Rosenberg metric: 0.5194674417181184
FCF margin (%): -117.21850875166308
Revenue growth (%): 126.2602410072915
Rule of 40 score: 9.041732255628418
Financial ratios for BCAT — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.93
Shares outstanding: 104775271
Market cap (USD): 1040418441.03
Buyback yield (%): 1.2578884114206732
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BCAT — annual report dated 2022-12-31
Total revenue: -320362215
Net income: -322523677
Capital expenditures: 0
Operating cash flow: 867860464
Net tangible assets: 1821348401
Owner earnings: -322523677
Return on net tangible assets (%): -17.70796168503074
Buffett classification: The Gruesome
Stock price: 7.68
Shares outstanding: 104775271
Book value: 1821348401
P/B ratio: 0.44180129449049876
Market cap (USD): 804674081.28
Debt to equity: 0.0009908971831029709
Free cash flow (dilution-adjusted): 867860464
Buyback yield (%): 6.5577235836975305
Retained earnings: -280890787
Receivables turnover: -2.074136551295054
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BCAT — annual report dated 2023-12-31
Total revenue: 206902583
Net income: 204724217
Capital expenditures: 0
Operating cash flow: 181325694
Net tangible assets: 1853695864
Owner earnings: 204724217
Return on net tangible assets (%): 11.044110362216356
Buffett classification: The Gruesome
Stock price: 9.16
P/E ratio: 4.687972416863609
Shares outstanding: 104775271
Book value: 1853695864
P/B ratio: 0.5177448474686784
Market cap (USD): 959741482.36
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 0.6352230991722322
Free cash flow (dilution-adjusted): 181325694
Buyback yield (%): 1.1980419947803245
Retained earnings: -137029970
Receivables turnover: 6.846348805700962
Capitalized R&D asset: 0
FCF margin (%): 87.63819734430285
Rule of 40 score: 87.63819734430285
Financial ratios for BCAT — annual report dated 2024-12-31
Total revenue: 197673074
Net income: 194418080
Capital expenditures: 0
Operating cash flow: 354885636
Net tangible assets: 1721260401
Owner earnings: 194418080
Return on net tangible assets (%): 11.295099793561102
Buffett classification: The Gruesome
Stock price: 10.94
P/E ratio: 5.895755501443075
Shares outstanding: 104775271
Book value: 1721260401
P/B ratio: 0.6659314674723642
Market cap (USD): 1146241464.74
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 1.1410987618880253
Free cash flow (dilution-adjusted): 354885636
Buyback yield (%): 3.957576862767715
Retained earnings: -274264
Receivables turnover: 17.752987726497057
Capitalized R&D asset: 0
FCF margin (%): 179.53160175978243
Revenue growth (%): -4.460799312495775
Rule of 40 score: 175.07080244728667
Financial ratios for BCAT — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 1721260401
Buffett classification: The Gruesome
Stock price: 10.94
Shares outstanding: 104775271
Book value: 1721260401
P/B ratio: 0.6659314674723642
Market cap (USD): 1146241464.74
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: -274264
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BCAT — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 1641742875
Buffett classification: The Gruesome
Stock price: 12.25
Shares outstanding: 104775271
Book value: 1641742875
P/B ratio: 0.7817893345509418
Market cap (USD): 1283497069.75
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: -79791790
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BDTX — annual report dated 2021-12-31
Capital expenditures: 2710000
Buffett classification: The Gruesome
Stock price: 5.33
Shares outstanding: 57301774
Market cap (USD): 305418455.42
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BDTX — annual report dated 2022-12-31
Total revenue: 0
Operating income: -92828000
Net income: -91169000
Capital expenditures: 183000
Operating cash flow: -85082000
Depreciation & amortization: 508000
Net tangible assets: 115695000
Owner earnings: -90844000
Return on net tangible assets (%): -78.5202472016941
Buffett classification: The Gruesome
Stock price: 1.8
Shares outstanding: 57301774
Book value: 115695000
P/B ratio: 0.8915095138078568
Market cap (USD): 103143193.2
Debt to equity: 0.2432257228056528
Current ratio: 8.36812790773868
Quick ratio: 8.36812790773868
Free cash flow (dilution-adjusted): -97471000
Buyback yield (%): 0
Retained earnings: -334989000
Capitalized R&D asset: 64437000
ROCI (R&D-adjusted, %): -24.275790898160455
Rule of 40 score: 0
Financial ratios for BDTX — annual report dated 2023-12-31
Total revenue: 0
Operating income: -86460000
Net income: -82442000
Capital expenditures: 62000
Operating cash flow: -66717000
Depreciation & amortization: 437000
Net tangible assets: 116736000
Owner earnings: -82067000
Return on net tangible assets (%): -70.3013637609649
Buffett classification: The Gruesome
Stock price: 2.81
Shares outstanding: 57301774
Book value: 116736000
P/B ratio: 1.3793344378769188
Market cap (USD): 161017984.94
Debt to equity: 0.21671121162280702
Current ratio: 6.822457497709458
Quick ratio: 6.822457497709458
Free cash flow (dilution-adjusted): -76354000
Buyback yield (%): 0
Retained earnings: -417431000
Capitalized R&D asset: 102522790
ROCI (R&D-adjusted, %): -28.318116333964667
Rule of 40 score: 0
Financial ratios for BDTX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.14
Shares outstanding: 57301774
Market cap (USD): 122625796.36000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BDTX — annual report dated 2024-12-31
Total revenue: 0
Operating income: -78781000
Net income: -69676000
Capital expenditures: 94000
Operating cash flow: -62303000
Depreciation & amortization: 343000
Net tangible assets: 83285000
Owner earnings: -69427000
Return on net tangible assets (%): -83.36074923455604
Buffett classification: The Gruesome
Stock price: 2.14
Shares outstanding: 57301774
Book value: 83285000
P/B ratio: 1.4723635271657562
Market cap (USD): 122625796.36000001
Debt to equity: 0.26638650417242
Current ratio: 4.917902104700335
Quick ratio: 4.917902104700335
Free cash flow (dilution-adjusted): -72930000
Buyback yield (%): 0
Retained earnings: -487107000
Capitalized R&D asset: 112340710
ROCI (R&D-adjusted, %): -40.033697171306635
Rule of 40 score: 0
Financial ratios for BDTX — quarterly report dated 2025-03-31
Total revenue: 70000000
Operating income: 54530000
Net income: 56542000
Capital expenditures: 13000
Operating cash flow: 53410000
Depreciation & amortization: 87000
Net tangible assets: 141516000
Owner earnings: 56616000
Return on net tangible assets (%): 40.00678368523701
Capex to operating income (%): 0.0238400880249404
Buffett classification: The Great
Stock price: 1.55
P/E ratio: 0.39270696871352273
Shares outstanding: 57301774
Book value: 141516000
P/B ratio: 0.6276163098165578
Market cap (USD): 88817749.7
Debt to equity: 0.15254105542836147
Current ratio: 9.240755030569241
Quick ratio: 9.240755030569241
COGS to revenue (%): 0
R&D to revenue (%): 15.008571428571429
SG&A to revenue (%): 7.091428571428571
Free cash flow (dilution-adjusted): 51710000
Buyback yield (%): 0
Retained earnings: -430565000
Capitalized R&D asset: 10506000
ROCI (R&D-adjusted, %): 36.2169224974103
FCF margin (%): 73.87142857142858
Rule of 40 score: 73.87142857142858
Financial ratios for BDTX — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -13420000
Net income: -10561000
Capital expenditures: 10000
Operating cash flow: -9159000
Depreciation & amortization: 86000
Net tangible assets: 132610000
Owner earnings: -10485000
Return on net tangible assets (%): -7.90664354121107
Buffett classification: The Gruesome
Stock price: 2.48
Shares outstanding: 57301774
Book value: 132610000
P/B ratio: 1.0716265705452077
Market cap (USD): 142108399.52
Debt to equity: 0.15648895256767967
Current ratio: 8.731091936923535
Quick ratio: 8.731091936923535
Free cash flow (dilution-adjusted): -10936000
Buyback yield (%): 0
Retained earnings: -441126000
Capitalized R&D asset: 16358020
ROCI (R&D-adjusted, %): -6.453815306060258
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for BDTX — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -10978000
Net income: -8498000
Capital expenditures: 1000
Operating cash flow: -7850000
Depreciation & amortization: 86000
Net tangible assets: 126152000
Owner earnings: -8413000
Return on net tangible assets (%): -6.668939057644746
Buffett classification: The Gruesome
Stock price: 3.79
P/E ratio: 5.793925871995304
Shares outstanding: 57301774
Book value: 126152000
P/B ratio: 1.7215242204642018
Market cap (USD): 217173723.46
Debt to equity: 0.15592301350751475
Current ratio: 8.941267288517208
Quick ratio: 8.941267288517208
Free cash flow (dilution-adjusted): -9589000
Buyback yield (%): 0
Retained earnings: -449624000
Capitalized R&D asset: 17147710
ROCI (R&D-adjusted, %): -7.92561399659457
Rule of 40 score: 0
Financial ratios for BDTX — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -10262000
Net income: -15116000
Capital expenditures: 3000
Operating cash flow: -6787000
Depreciation & amortization: 66000
Net tangible assets: 112211000
Owner earnings: -15053000
Return on net tangible assets (%): -13.414905847020345
Buffett classification: The Gruesome
Stock price: 2.43
P/E ratio: 6.225390567353691
Shares outstanding: 57301774
Book value: 112211000
P/B ratio: 1.2409060682107815
Market cap (USD): 139243310.82000002
Debt to equity: 0.16737218276283075
Current ratio: 8.419045197380967
Quick ratio: 8.419045197380967
Free cash flow (dilution-adjusted): -8199000
Buyback yield (%): 0
Retained earnings: -464740000
Capitalized R&D asset: 14354060
ROCI (R&D-adjusted, %): -8.225480689324936
Rule of 40 score: 0
Financial ratios for BDTX — annual report dated 2025-12-31
Total revenue: 70000000
Operating income: 19870000
Net income: 22367000
Capital expenditures: 27000
Operating cash flow: 29614000
Depreciation & amortization: 325000
Net tangible assets: 112211000
Owner earnings: 22665000
Return on net tangible assets (%): 20.19855450891624
Capex to operating income (%): 0.13588324106693508
Buffett classification: The Great
Stock price: 2.43
P/E ratio: 6.225390567353691
Shares outstanding: 57301774
Book value: 112211000
P/B ratio: 1.2409060682107815
Market cap (USD): 139243310.82000002
Debt to equity: 0.16737218276283075
Current ratio: 8.419045197380967
Quick ratio: 8.419045197380967
COGS to revenue (%): 0
R&D to revenue (%): 47.94
SG&A to revenue (%): 23.674285714285716
Free cash flow (dilution-adjusted): 22986000
Buyback yield (%): 0
Retained earnings: -464740000
Capitalized R&D asset: 87522540
ROCI (R&D-adjusted, %): 2.492843704317327
FCF margin (%): 32.83714285714286
Rule of 40 score: 32.83714285714286
Financial ratios for BIPS.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.018513513513513515
Shares outstanding: 265828911
Market cap (USD): 4921427.136081082
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BIPS.L — annual report dated 2022-12-31
Total revenue: -40754216.867469884
Net income: -41713253.01204819
Capital expenditures: 0
Operating cash flow: 15397590.361445785
Net tangible assets: 338661445.78313255
Owner earnings: -41713253.01204819
Return on net tangible assets (%): -12.317095297219028
Buffett classification: The Gruesome
Stock price: 0.01566265060240964
Shares outstanding: 265828911
Book value: 338661445.78313255
P/B ratio: 0.012294240767159155
Market cap (USD): 4163585.3530120486
Debt to equity: 0.19122413185859283
Free cash flow (dilution-adjusted): 15397590.361445785
Buyback yield (%): 0
Receivables turnover: -164.20388349514565
Capitalized R&D asset: 0
Rule of 40 score: 0